Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Neural Network-based Isolectin B 4 Flat-Mount Analysis in a Novel AAV-hVEGF-Induced Diabetic Retinopathy Animal Model

Inesa Lelyte; Symantas Ragauskas; Marius Dragasius; Zubair Ahmed; Giedrius Kalesnykas; Nerija Kvietkauskiene

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2333.

ARVO Annual Meeting Abstract June 2023

Aflibercept exerts structural protection against diabetic retinopathy-associated inner retinal abnormalities in the mouse STZ model

Symantas Ragauskas; Tomas Paulauskas; Inesa Lelyte; Donatas Neverauskas; Kernius Mickevicius; Robertas Cesna; Giedrius Kalesnykas; Simon Kaja

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):556.

ARVO Annual Meeting Abstract June 2023

AAV-mediated expression of human VEGF-A as a novel rat model of diabetic retinopathy

Inesa Lelyte; Symantas Ragauskas; Tomas Paulauskas; Zubair Ahmed; Simon Kaja; Giedrius Kalesnykas

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1820.

ARVO Annual Meeting Abstract June 2023

Involvement of thioredoxin system in laser induced CNV mouse model

Robertas Cesna; Dovile Litvinaviciute; Justina Urbanaviciute; Inesa Lelyte; Kernius Mickevicius; Odeta Adamoniene; Donatas Neverauskas; Symantas Ragauskas; Giedrius Kalesnykas; Anita K. Ghosh; Simon Kaja

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2727.

ARVO Annual Meeting Abstract June 2022

Title. Development of human retinal pigment epithelial cells with inducible VEGF expression

Inesa Lelyte; Vidhya R. Rao; Zubair Ahmed; Giedrius Kalesnykas; Simon Kaja

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3608 – A0063.

ARVO Annual Meeting Abstract June 2020

Comparative efficacy of bevacizumab and aflibercept in the rabbit DL-AAA model of chronic retinal neovascularization

Robertas Cesna; Tomas Paulauskas; Kernius Mickevicius; Donatas Neverauskas; Inesa Lelyte; Simon Kaja; Giedrius Kalesnykas; Symantas Ragauskas

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5391.

Advertisement